| Authors: |
Langhout SAM; Performation Healthcare, Zeist, the Netherlands., Hermans SJF; Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Smit AJT; Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Berkx E; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Kurk SA; Performation Healthcare, Zeist, the Netherlands., Schade KJ; Performation Healthcare, Zeist, the Netherlands., Posthuma EFM; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, the Netherlands.; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Cornelissen JJ; Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Huijgens PC; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands., Versluis J; Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., van der Wilt M; Performation Healthcare, Zeist, the Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Erasmus MC, Department of Public Health, University Medical Center Rotterdam, Rotterdam, the Netherlands. |
